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Abstract 
High throughput screening, where thousands of molecules rapidly can be assessed for activity 
against a protein, has been the dominating approach in drug discovery for many years. However, 
these methods are costly and require much time and effort. In order to suggest an improvement 
to this situation we, in this study, apply an iterative screening process where an initial set of 
compounds are selected for screening based on molecular docking. The outcome of the initial 
screen is then used to classify the remaining compounds through a conformal predictor. The 
approach was retrospectively validated using 41 targets from the Directory of Useful Decoys, 
Enhanced (DUD-E), ensuring scaffold diversity among the active compounds. The results show 
that 57% of the remaining active compounds could be identified while only screening 9.4% of 
the database. The overall hit rate (7.6%) was also higher than when using docking alone (5.2%). 
When limiting the search to the top scored compounds from docking, 39.6% of the active 
compounds could be identified compared to 13.5% when screening the same number of 
compounds solely based on docking. The use of conformal predictors also gives a clear 
indication of the number of compounds to screen in the next iteration. These results indicate that 
iterative screening based on molecular docking and conformal prediction can be an efficient way 
to find active compounds while screening only a small part of the compound collection. 
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Introduction 
The introduction of high throughput screening (HTS) in drug discovery ushered in an era 
where the aim of many screening campaigns became to screen as large collection of compounds 
as possible to maximize the chances of finding compounds with promising activities.
1
 Although 
HTS is a useful tool in many cases,
2
 these approaches are resource-intensive, and hence 
alternative approaches to screening can be taken.
3
 
Recently, iterative screening where the results of an initial smaller screen are used to guide 
further compound selection for the next round of screening, has been shown to increase 
screening efficiency.
4–7
 Maciejewski et al. presented a iterative screening strategy based on 
selecting compound with a low but positive score from a Naı̈ve Bayes model in order to increase 
the chemical diversity of the screening hits.
4
 Also, Paricharak et al. demonstrated on Novartis in-
house data that iterative screening can aid in the effective screening of bioactive molecules by 
selecting compounds for screening based on biological and chemical similarities to the hits from 
the previous iteration.
5
 This approach consistently retrieved a high number of active compounds 
with only a small fraction of the total screening collection screened. Similarly, there have been 
attempts to define an 'informer set' of a small compound collection which can be screened 
initially, and which can be used to predict the activity against a wide variety of biological targets 
in turn, with the same rationale in mind.
7
 
The downside of iterative screening is the difficulties associated with having to conduct 
screening at multiple occasions and using individually picked compounds. To some extent this 
has been mitigated by the recent improvements in screening technologies and atomization as it is 
now feasible to conduct screening also in smaller scale while maintaining reasonable efficiency. 
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On the other hand, the upside is that compared to traditional HTS a much smaller set of 
compounds might need to be screened in order to identify the same number of active compounds.  
In order to use the results from the first screening iteration to determine what compounds to 
screen next, a number of active molecules needs to be identified. As virtual screening (VS) 
generally achieves higher hit rate than random screening,
8
 VS is a promising approach for 
selecting the initial screening set. 
A conformal predictor is a type of confidence predictor, generating prediction intervals that are 
guaranteed to be valid in accordance to a user set confidence level.
9
 Conformal prediction paired 
with support vector machines and random forests have previously been shown to be promising 
approaches to model bioactivities.
10–13
 Three features of conformal prediction makes it an 
attractive choice for modeling compound activities. Firstly, the guaranteed error rate gives the 
user a way to control the maximum number of false positives that can be accepted. Secondly, 
conformal prediction handles imbalanced data very well.
12,14,15
 Lastly, the number of predicted 
active compounds will provide insight into how many compounds should be screened in the next 
iteration. 
The evaluation of virtual screening techniques typically relies on retrospective analysis of 
benchmark datasets. DUD
16
 and the improved version DUD-E
17
 are among the most frequently 
used benchmark datasets used for the evaluation of virtual screening. By design DUD and DUD-
E are intended to be used primarily for docking, but it has also been used to evaluate ligand-
based techniques.
18
 
In this work, we now combine iterative screening based on conformal prediction with an initial 
virtual screening step to identify a first screening set. The workflow is shown schematically in 
Figure 1. First the compound library is docked to the respective targets. For each target, based on 
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the docking score, the top one percent of all compounds are selected for a first iteration of 
screening. Based on these results a classification model is trained and used to predict the 
activities of the remaining compounds. 
 The suggested iterative screening approach was evaluated retrospectively on 41 targets from 
DUD-E. The results indicate that this approach can increase the hit rate in screening while also 
providing guidance on the number of compounds that should be screened in each iteration. 
Methods 
Iterative screening 
The top one percent of each dataset selected by docking constitutes the first iteration of 
screening. Based on the compounds true activities conformal predictors were trained to classify 
the remaining compounds in each dataset. In order to be able to train a classification model on 
the data, a requirement was added that the active and inactive classes needed to be represented 
by at least ten compounds each. The compounds receiving a single label prediction as active are 
then advanced to the next iteration of screening. The cycle of predictions and screening is then 
repeated until the desired number of active compounds have been identified or the predictions 
indicate that there is little gain in additional screening. 
Ligand preparation 
Ligands, both active and decoys, were downloaded from the DUD-E webpage 
(http://dude.docking.org/) and prepared for docking using LigPrep
19
 version 2.6 with the default 
settings. 
Docking 
Proteins were prepared for docking using the protein preparation wizard
20
 in Maestro with the 
default settings and grids for docking were generated using the grid generation tool in Glide
21–23
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version 5.9 centering the grid (16 Å) on the co-crystallized ligand. Glide has previously been 
shown to have excellent performance compared to other docking software when evaluated on the 
DUD data sets.
24
 Docking was performed using Glide in Standard Precision mode at the default 
settings. From the ligand preparation each compound can be present in the database in different 
chiral, protonation, and tautomeric states. When ranking compounds only the highest scored 
form of a compound was considered. 
Feature generation 
For machine learning the structures were neutralized and salts removed using CORINA
25
. 
Structure standardization was performed using the IMI eTOX project standardizer
26
 in 
combination with tautomer standardization using the MolVS standardizer
27
. 97 different 
structural and physiochemical descriptors were calculated using RDKit
28
 (complete list in 
Supporting Information). These descriptors have previously been used for successful modeling 
of activity data.
15
 
Similarity ranking 
Similarity ranking was performed by calculating the Euclidian distance in normalized RDKit 
space (scaled to zero mean and unit variance) to the active reference compounds. Compounds 
were ranked by their distance to the closest active compound. 
Machine learning 
A conformal predictor is a type of confidence predictor, i.e. it gives predictions with a 
guaranteed error rate. In this setting it is achieved by comparing new compounds to compounds 
of known outcome in a calibration set. The predictor then assigns a label to the new compound 
for each class where it is similar enough (according to a user set cut-off) to the calibration 
examples. A conformal predictor therefore outputs a set of predicted labels as opposed to 
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assigning only a single label to each compound. Thus for a binary classification problem, a 
compound can be classified as either of the two classes but also to both classes, both, or to none 
of the classes, empty. A conformal predictor is said to be valid if the frequency of errors does not 
exceed the set significance level (defined as 1-confidence level). When evaluating the validity of 
the predictor a both classification is always considered correct and an empty always incorrect. 
For a more in depth example of the conformal prediction algorithm we refer the reader to a 
recent paper by Norinder et al.
13
 
The confidence in a prediction is evaluated by calculating the nonconformity score for the new 
compound and insert that number in a ordered list of nonconformity scores from the calibration 
set. This has the consequence that the resolution available in the assessment of the confidence is 
dependent of the number of compounds in the calibration set (as this will determine the number 
of positions available in the ranked list). In this studies some datasets have very few examples in 
the calibration set effectively limiting the resolution. 
The training data was split into training (70%) and calibration set (30%) in a stratified manner 
to ensure a proportional distribution of the two classes. We used aggregated models, repeating 
the sampling 100 times and using the median prediction from the ensemble.
29
 Performance was 
evaluated with respect to the accuracy of the predictions but also with respect to their validity. 
In this study we use the term coverage to describe the fraction of compounds with a single 
label prediction and accuracy to describe the fraction of correct classification for the compounds 
with single label predictions. 
Models were developed using Python, Scikit-learn
30
 version 0.17, and the nonconformist 
package
31
 version 1.2.5. The underlying methods for the conformal predictors were binary 
random forest
32
 classification models built using the Scikit-learn RandomForestClassifier with 
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500 trees and all other options set at default. Class conditional conformal predictions were 
performed using the ProbEstClassifierNC and IcpClassifier functions in the nonconformist 
package. 
Results and Discussion 
Docking to identify the first screening set 
41 targets from DUD-E were selected for the study. The first step of our protocol was to dock 
all compounds against their respective targets. A summary of the datasets and the number of 
active compounds selected by docking is shown in Table 1.  
For each target we chose the top one percent of the compounds based on the docking score. 
This selected an average of 31.9% active compounds across all the datasets, considerably better 
performance compared to the expected 1.6% if the compounds had been selected at random. This 
selection constitutes the first screening set and the activities of these compounds was used in the 
next steps to train conformal predictors. 
Conformal prediction models for next iteration 
32 datasets had a sufficient number of active and inactive compounds to allow for the training 
of a conformal predictor. We chose to use RDKit molecular descriptors as features for the 
machine learning. One motivation for this was to avoid artificially high enrichments that can be 
seen when using fingerprint based descriptors on the DUD-E datasets since the decoys are 
chosen to be diverse from the active compounds in ECFP space.
17
 However, the method 
presented in this paper is not limited to the features applied here but can easily be extended to 
any input features desired. Once trained, we applied the respective model to classify all 
remaining compounds in the dataset at the 90% confidence level. The model statistics are shown 
in Table 2. 
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The models achieved an average validity of 85.5% for the inactive class and 60.0% for the 
active class. This is less than the 90% validity expected from the set significance level (see 
methods section). However, this is not surprising as a small subset of compounds is unlikely to 
cover the diversity of the full database. We would like to stress that this is not a limitation linked 
specifically to the conformal prediction algorithm but something that will pose a problem for any 
machine learning approach applied to this problem. 
We next compared the number of active compound selected by the classification model as well 
as the number of active compounds selected by docking when screening the same number of 
compounds, the results of which are shown in Table 3. Overall, 57% of the active compounds 
and 8.8% of the inactive compounds were predicted as active by the models. This equaled a total 
average of 9.4% of all remaining compounds being predicted as active and screening of these 
compounds would have resulted in a hit rate of 7.6%. If instead, for each dataset, the 
corresponding number of compounds had been selected based on the docking scores the hit rate 
would have been 4.6% with only three datasets having higher hit rate compared to the conformal 
prediction (see Table 3). Also, selecting the top 10% from each dataset based on docking score 
(see Supporting Information) would have resulted in a hit rate of 5.2%. Due to the design of the 
DUD-E datasets where the active compounds are selected from clusters based on their Bemis-
Murcko scaffolds, these results also reflects an excellent scaffold diversity.
17,33
 
To generate a baseline for comparison we also calculated the number of actives located based 
on similarity to the initial active compounds in the same descriptor space used to train the 
predictors (Supporting Information). When allowed to select the same number of compounds as 
the conformal predictor this approach produced an average hit rate of 6.4%, lower than the 
average hit rate of the conformal predictor. 
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A major attraction with conformal prediction in this context is the guidance given with regards 
to the number of compounds to screen. In the conformal prediction framework the number of 
compounds to further screen can be derived from the number of single class predictions found at 
the, by the user, set confidence level. Hence, the models, based on the underlying data, are able 
to give guidance on how many compound to screen in a subsequent step based on the level of 
uncertainty that is acceptable to the user. 
We also tried applying an approach not requiring extra rounds of experimental screening by 
training the models based on the docking results alone, considering top scoring compounds as 
active and bottom scoring compounds as inactive (see Supporting Information, Table S4). When 
set up in this way, these models did not improve the results compared to docking. It is also 
important to remember that in the context of conformal prediction training the models on 
computational data alone will remove the statistical guarantees of the predictor as the calibration 
set will include examples with the wrong label. However, the design of a purely computational 
pipeline using similar approaches represents an interesting area for future research. 
Using only top scored compounds from docking 
In an effort to improve the model validity, we investigated the effects on prediction validity 
and model outcome when using the derived classification models to predict the remaining 
compounds from the top ten percent ranked by docking. The rationale behind this is that these 
compounds should be more similar to the top one percent of compounds used to train the 
classifier and the models should therefore have increased validities. The downside is that active 
compounds that are not in the top ten percent based on docking cannot be identified. 
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The model statistics from the predictions on the top ten percent of the database are shown in 
Table 4. Compared to predicting the full database the validities are higher, achieving an average 
validity of 89.6% and 70.9% for the inactive and active classes, respectively. 
The number of active compounds selected by the predictive models as well as the 
corresponding results from docking and similarity search are shown in Table 5. Using this 
approach, screening all the compounds predicted to be active, would achieve a hit rate of 39.6% 
while selecting the same number of compounds based on docking would have resulted in a hit 
rate of 13.5%. The high hit rate can be attributed to the high validity of the predictions for the 
inactive class drastically limiting the number of false positives. As long as the predictions are 
valid, at the 90% confidence level, at most 10% of the inactive compounds can be wrongly 
classified as active. 
One of the advantages with the approach presented in this paper is the inherent flexibility of 
the methods. The conformal prediction framework allows any machine learning algorithm to be 
used and the initial VS can be conducted using a VS method of choice. Thus, current methods 
already in place can easily be adapted to be applied within the presented framework. 
Conclusions 
In this study we present an iterative screening approach, which is based on initial compound 
ranking by molecular docking and subsequent compound selection by conformal prediction. By 
using docking to select the first compounds for screening a number of active molecules can be 
identified while screening only a small fraction of the database, thus allowing for the training of 
conformal predictors in order to select the compounds for the next iteration of screening. Using 
this approach, high hit rates can be achieved while screening only parts of the total compound 
collection. In this study 57% of the active compounds could be located by screening 9.4% of the 
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database. The average hit rate from the conformal predictors (7.6%) was also higher than using 
docking alone (5.2%). When classifying only compounds from the top ten percent based on their 
docking score, 39.6% of the available active compounds where selected while selecting the same 
number of compounds based on docking resulted in a hit rate of 13.5%. The conformal 
predictors also provide guidance on the number of compounds to screen in the next iteration 
based on a user defined confidence level. 
Supporting Information 
List of RDKit descriptors used for machine learning. Number of actives found when screening 
an additional 1%, and 9% of the database based on the docking score. Number of actives found 
when using similarity in RDKit descriptor space. 
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Figure 1. Overview of the workflow presented in this study. An initial docking study is used 
to select compounds for a first screening set. The activities of the selected compounds are then 
experimentally evaluated and the results are used to train a conformal predictor. This predictor is 
then used to classify the remaining compounds in order to select the next set for screening. This 
iteration, testing and prediction, can be repeated until the desired number of active compounds 
has been identified. 
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Table 1. Number of compounds and number of active compounds in the whole datasets as well 
as in the top 1 % based on docking score. It can be seen that for most datasets docking finds a 
high number of active compounds in the top 1 %. 
Dataset Inactive 
compounds 
Active 
compounds 
Compounds 
in top 1 % 
Active in 
top 1 % 
ABL1 10,746 182 109 37 
ACES 26,233 453 267 64 
ADA 5,449 93 55 6 
AMPC 2,832 48 29 9 
ANDR 14,343 269 146 54 
BRAF 9,942 152 101 44 
CASP3 10,692 199 109 56 
CSF1R 12,143 166 123 44 
CXCR4 3,406 40 33 1 
DPP4 40,915 533 414 15 
DRD3 34,022 480 345 28 
DYR 17,170 231 174 48 
EGFR 35,020 542 356 106 
FNTA 51,430 592 520 54 
GCR 14,986 258 152 44 
GRIK1 6,546 101 66 27 
HDAC8 10,448 170 106 6 
HIVRT 18,879 338 192 61 
HS90A 4,802 88 49 3 
JAK2 6,495 107 66 33 
KIF11 6,848 116 70 57 
KITH 2,850 57 29 28 
KPCB 8,692 135 88 21 
MAPK2 6,147 101 62 37 
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MK01 4,548 79 46 17 
MK14 35,810 578 364 85 
MP2K1 8,147 121 83 17 
NOS1 8,050 100 82 11 
PA2GA 5,146 99 52 33 
PARP1 30,035 508 305 210 
PDE5A 27,520 398 279 61 
PGH2 23,135 435 236 133 
PNPH 6,950 103 71 32 
PPARA 19,356 373 197 61 
PPARG 25,256 484 257 98 
PUR2 2,694 50 27 27 
PYRD 6,446 111 66 44 
RENI 6,955 104 71 25 
SAHH 3,450 63 35 35 
TRY1 25,914 449 264 132 
WEE1 6,148 102 63 63 
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Table 2. Validity, coverage and accuracy of the conformal predictor at 90 % confidence level for 
all datasets when applied to all the remaining compounds. It can be seen that the validities, 
especially for the active class, are below the expected value (0.9). 
Dataset Validity 
inactive 
Validity 
active 
Coverage 
inactive 
Coverage 
active 
Accuracy 
inactive 
Accuracy 
active 
ABL1 77.6 86.2 59.1 88.3 62.1 84.4 
ACES 87.0 52.2 94.8 95.9 86.3 50.1 
ANDR 88.9 72.1 96.7 95.8 92.0 75.2 
BRAF 95.1 73.1 98.4 95.4 95.4 73.8 
CASP3 93.8 17.5 95.3 92.3 98.5 18.9 
CSF1R 79.6 71.3 87.9 82.8 76.8 65.3 
DPP4 80.0 96.5 45.4 66.2 55.9 94.8 
DRD3 73.7 64.4 88.7 85.6 83.0 75.2 
DYR 91.9 79.2 92.1 87.4 99.8 90.6 
EGFR 81.2 44.0 81.3 54.8 99.8 80.3 
FNTA 93.6 55.9 96.0 86.1 97.5 65.0 
GCR 86.7 14.0 87.5 57.9 99.0 24.2 
GRIK1 96.0 10.8 96.6 87.8 99.4 12.3 
HIVRT 77.8 69.0 54.4 64.6 59.2 52.0 
JAK2 98.5 89.2 74.9 58.1 98.0 81.4 
KIF11 99.8 28.8 88.7 74.6 99.8 4.5 
KPCB 88.5 47.4 88.7 84.2 99.7 56.3 
MAPK2 99.2 42.2 99.5 95.3 99.2 39.3 
MK01 96.1 46.8 98.0 88.7 96.8 50.9 
MK14 82.1 60.9 89.4 89.5 91.9 68.0 
MP2K1 78.5 16.3 80.1 75.0 98.0 21.8 
NOS1 56.1 96.6 57.0 87.6 22.9 96.2 
PA2GA 86.6 47.0 87.0 87.9 99.6 53.4 
PARP1 76.4 80.5 90.2 92.6 84.7 87.0 
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PDE5A 86.5 96.7 59.8 82.5 77.4 96.0 
PGH2 86.2 27.2 86.6 75.8 99.5 35.8 
PNPH 94.4 98.6 97.5 98.6 96.8 100 
PPARA 72.2 79.2 83.3 88.5 86.7 89.5 
PPARG 67.9 69.4 79.3 85.0 85.6 81.7 
PYRD 97.8 34.3 98.5 98.5 99.3 34.8 
RENI 90.8 83.5 97.2 98.7 93.4 84.6 
TRY1 74.9 70.3 76.0 76.0 98.5 92.5 
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Table 3. Number of compounds predicted to be active by the conformal predictors for each 
dataset, the number of true active compounds from the predictions as well as the number of 
active compounds that would have been identified when screening the same number of 
compounds based on docking score. The highest number of active compound for each dataset is 
indicated in bold. Overall, the conformal predictor locates more active compounds compared to 
docking. 
Dataset Compounds 
evaluated 
Conformal 
active 
Docking 
active 
ABL1 2,499 108 80 
ACES 3,570 187 159 
ANDR 1,260 155 66 
BRAF 526 76 50 
CASP3 179 25 15 
CSF1R 2,523 66 102 
DPP4 8,439 325 232 
DRD3 5,367 291 219 
DYR 175 145 21 
EGFR 254 192 17 
FNTA 1,518 301 68 
GCR 155 30 5 
GRIK1 47 8 4 
HIVRT 4,257 93 168 
JAK2 134 35 26 
KIF11 16 2 7 
KPCB 76 54 4 
MAPK2 70 24 18 
MK01 169 28 14 
MK14 2,864 300 70 
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MP2K1 149 17 8 
NOS1 3,580 75 60 
PA2GA 51 31 8 
PARP1 4,360 240 230 
PDE5A 3,949 267 176 
PGH2 175 82 32 
PNPH 286 70 39 
PPARA 2,373 247 174 
PPARG 3,124 268 232 
PYRD 69 23 9 
RENI 506 66 34 
TRY1 516 223 80 
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Table 4. Validity, coverage and accuracy of the conformal predictor at 90 % confidence level for 
all datasets when applied to the top ten percent of compounds ranked by docking. This approach 
achieves validities closer to the expected (0.9) compared to when predicting the full dataset 
(Table 2). 
Dataset Validity 
inactive 
Validity 
active 
Coverage 
inactive 
Coverage 
active 
Accuracy 
inactive 
Accuracy 
active 
ABL1 91.2 75.7 79.4 81.1 89.0 70.0 
ACES 91.9 72.7 98.0 95.3 91.7 71.3 
ANDR 91.3 70.1 97.1 91.0 94.0 77.0 
BRAF 90.8 79.4 98.1 100 91.0 79.4 
CASP3 92.7 62.5 94.7 87.5 97.9 71.4 
CSF1R 84.4 77.3 88.7 78.8 82.4 71.2 
DPP4 87.0 96.5 44.6 69.9 70.7 94.9 
DRD3 87.3 80.6 94.9 91.7 92.0 87.9 
DYR 91.1 90.8 91.3 92.9 99.8 97.8 
EGFR 85.8 50.4 86.2 63.0 99.6 80.0 
FNTA 93.2 58.8 95.5 82.9 97.6 70.9 
GCR 91.1 23.1 91.5 50.0 99.6 46.2 
GRIK1 97.7 17.5 98.0 92.5 99.6 18.9 
HIVRT 86.3 83.9 57.9 66.1 76.3 75.7 
JAK2 96.5 85.4 77.8 75.0 95.5 80.6 
KIF11 99.5 40.5 90.0 62.2 99.4 4.3 
KPCB 91.3 37.9 91.3 79.3 100 47.8 
MAPK2 98.6 47.1 99.0 96.1 98.6 44.9 
MK01 92.4 78.3 94.4 91.3 92.2 76.2 
MK14 86.3 73.3 90.8 88.0 94.9 83.3 
MP2K1 83.9 46.4 84.6 78.6 99.2 59.1 
NOS1 71.4 95.7 46.8 93.6 38.9 95.5 
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PA2GA 92.4 91.7 94.0 100 98.3 91.7 
PARP1 82.1 88.0 95.5 95.9 86.1 91.8 
PDE5A 94.1 94.9 69.8 87.0 91.6 94.2 
PGH2 88.8 51.8 88.9 84.7 99.8 61.1 
PNPH 94.5 100 97.4 100 97.0 100 
PPARA 82.7 84.1 89.8 90.7 92.1 92.7 
PPARG 82.4 80.1 89.3 91.9 92.3 87.1 
PYRD 96.6 62.1 97.7 93.1 98.9 66.7 
RENI 91.3 91.9 98.5 100 92.7 91.9 
TRY1 81.2 80.0 82.2 83.3 98.8 96.0 
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Table 5. The number of compounds selected for screening by the predictive models when 
applied to the top ten percent of the database selected by docking, as well as the number of active 
compounds identified by the model and docking. The highest number of active compound for 
each dataset is indicated in bold. The conformal predictors perform better or equally good as 
docking across all data sets. 
Dataset Compounds 
evaluated 
Conformal 
active 
Docking 
active 
ABL1 104 21 5 
ACES 271 87 27 
ANDR 120 47 17 
BRAF 125 50 19 
CASP3 39 20 6 
CSF1R 200 37 27 
DPP4 547 75 25 
DRD3 340 116 15 
DYR 92 89 11 
EGFR 71 60 7 
FNTA 219 117 13 
GCR 11 6 0 
GRIK1 9 7 1 
HIVRT 278 56 39 
JAK2 48 29 9 
KIF11 4 1 1 
KPCB 11 11 0 
MAPK2 29 22 10 
MK01 45 16 7 
MK14 202 55 18 
MP2K1 18 13 1 
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NOS1 238 42 30 
PA2GA 29 22 6 
PARP1 528 191 132 
PDE5A 252 113 15 
PGH2 48 44 14 
PNPH 64 47 16 
PPARA 243 127 48 
PPARG 314 169 66 
PYRD 24 18 6 
RENI 77 34 13 
TRY1 166 144 38 
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